Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Coinstar, Inc. (CSTR)?

Page 1 of 2

Is Coinstar, Inc. (NASDAQ:CSTR) the right investment to pursue these days? The smart money is taking a bullish view. The number of long hedge fund positions inched up by 4 lately.

Coinstar, Inc. (NASDAQ:CSTR)

In today’s marketplace, there are many methods investors can use to watch publicly traded companies. Some of the most innovative are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top investment managers can outclass their index-focused peers by a superb amount (see just how much).

Equally as key, bullish insider trading sentiment is another way to break down the stock market universe. There are a variety of stimuli for a corporate insider to get rid of shares of his or her company, but only one, very obvious reason why they would buy. Several academic studies have demonstrated the market-beating potential of this strategy if investors know where to look (learn more here).

Keeping this in mind, let’s take a peek at the recent action encompassing Coinstar, Inc. (NASDAQ:CSTR).

How have hedgies been trading Coinstar, Inc. (NASDAQ:CSTR)?

At the end of the first quarter, a total of 36 of the hedge funds we track were bullish in this stock, a change of 13% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were boosting their holdings meaningfully.

According to our comprehensive database, David Cohen and Harold Levy’s Iridian Asset Management had the most valuable position in Coinstar, Inc. (NASDAQ:CSTR), worth close to $87.6 million, accounting for 1.3% of its total 13F portfolio. The second largest stake is held by Fine Capital Partners, managed by Debra Fine, which held a $71 million position; the fund has 7% of its 13F portfolio invested in the stock. Some other hedgies with similar optimism include Peter S. Park’s Park West Asset Management, Jeffrey Altman’s Owl Creek Asset Management and Ken Fisher’s Fisher Asset Management.

Now, key money managers have jumped into Coinstar, Inc. (NASDAQ:CSTR) headfirst. Iridian Asset Management, managed by David Cohen and Harold Levy, created the most valuable position in Coinstar, Inc. (NASDAQ:CSTR). Iridian Asset Management had 87.6 million invested in the company at the end of the quarter. Jeffrey Altman’s Owl Creek Asset Management also initiated a $65.4 million position during the quarter. The following funds were also among the new CSTR investors: Ken Fisher’s Fisher Asset Management, Yale M. Fergang and Robert W. Medway’s Royal Capital, and Bruce Kovner’s Caxton Associates LP.

How have insiders been trading Coinstar, Inc. (NASDAQ:CSTR)?

Insider trading activity, especially when it’s bullish, is best served when the company in question has experienced transactions within the past half-year. Over the latest six-month time frame, Coinstar, Inc. (NASDAQ:CSTR) has seen zero unique insiders purchasing, and 8 insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Coinstar, Inc. (NASDAQ:CSTR). These stocks are Office Depot Inc (NYSE:ODP), EZCORP Inc (NASDAQ:EZPW), Francesca’s Holdings Corp (NASDAQ:FRAN), Five Below Inc (NASDAQ:FIVE), and Vitamin Shoppe Inc (NYSE:VSI). All of these stocks are in the specialty retail, other industry and their market caps match CSTR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!